8-KThe WireStrategic
Material Agreement · Equity Issuance
Filed Dec 2, 2019 · 6y ago · Accession 0001564590-19-044971
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Xenon Pharmaceuticals Inc.
- Ticker
- XENE
- CIK
- 1582313
- Form type
- 8-K
- Filing date
- Dec 2, 2019
- Report date
- Dec 2, 2019
- Document
- xene-8k_20191202.htm
- Size
- 1.6 MB